Frédéric Bert

1.6k total citations
36 papers, 1.2k citations indexed

About

Frédéric Bert is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Frédéric Bert has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Infectious Diseases and 14 papers in Molecular Medicine. Recurrent topics in Frédéric Bert's work include Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Amoebic Infections and Treatments (6 papers). Frédéric Bert is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Amoebic Infections and Treatments (6 papers). Frédéric Bert collaborates with scholars based in France, Spain and United States. Frédéric Bert's co-authors include Marie-Hélène Nicolas-Chanoine, Jacques Belghiti, Richard Moreau, Javier Fernández, Véronique Leflon‐Guibout, Estelle Marcon, François Durand, Sylvie Janny, N Lambert-Zechovsky and Cathérine Paugam‐Burtz and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Frédéric Bert

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Bert France 17 449 342 340 271 225 36 1.2k
Maristela Pinheiro Freire Brazil 23 511 1.1× 184 0.5× 545 1.6× 189 0.7× 76 0.3× 71 1.3k
Heidrun Kerschner Austria 17 356 0.8× 109 0.3× 152 0.4× 185 0.7× 169 0.8× 32 922
Jin‐Yong Jeong South Korea 24 529 1.2× 218 0.6× 281 0.8× 447 1.6× 28 0.1× 47 1.4k
Belén Viñado Spain 16 565 1.3× 229 0.7× 120 0.4× 218 0.8× 322 1.4× 36 959
Shellee A. Grim United States 18 423 0.9× 139 0.4× 169 0.5× 420 1.5× 43 0.2× 35 1.1k
Hae Suk Cheong South Korea 18 430 1.0× 59 0.2× 350 1.0× 289 1.1× 134 0.6× 52 1.0k
E.-C. Kim South Korea 13 678 1.5× 78 0.2× 370 1.1× 554 2.0× 55 0.2× 17 1.3k
Laurel C. Preheim United States 22 687 1.5× 83 0.2× 218 0.6× 283 1.0× 140 0.6× 51 1.3k
M. Kalin Sweden 22 1.0k 2.3× 83 0.2× 211 0.6× 295 1.1× 48 0.2× 44 1.5k
Miguel Montejo Spain 17 923 2.1× 249 0.7× 91 0.3× 634 2.3× 78 0.3× 27 1.3k

Countries citing papers authored by Frédéric Bert

Since Specialization
Citations

This map shows the geographic impact of Frédéric Bert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Bert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Bert more than expected).

Fields of papers citing papers by Frédéric Bert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Bert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Bert. The network helps show where Frédéric Bert may publish in the future.

Co-authorship network of co-authors of Frédéric Bert

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Bert. A scholar is included among the top collaborators of Frédéric Bert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Bert. Frédéric Bert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beydon, Maxime, Yann Nguyen, Olivier Roux, et al.. (2025). Short versus long-course antibiotic therapy for pyogenic liver abscess: an emulated target trial. Clinical Microbiology and Infection. 32(2). 292–298.
2.
Grégory, Jules, Frédéric Bert, Anna Pellat, et al.. (2024). Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study. Therapeutic Advances in Medical Oncology. 16. 12703176–12703176.
3.
Pham, Tài, Stéphane Gaudry, Hafid Ait‐Oufella, et al.. (2024). Community-acquired Klebsiella pneumoniae pneumonia in ICU: a multicenter retrospective study. Annals of Intensive Care. 14(1). 69–69. 4 indexed citations
4.
Oliosi, Emma, G. Rossi, Yann Nguyen, et al.. (2023). Enterococcal pyogenic liver abscesses: high risk of treatment failure and mortality. European Journal of Clinical Microbiology & Infectious Diseases. 42(2). 193–199. 4 indexed citations
5.
6.
Rossi, G., Yann Nguyen, Emmanuel Lafont, et al.. (2022). Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses. Infection. 50(5). 1205–1215. 12 indexed citations
7.
Rossi, Benjamín, Sylvain Brisse, Dominique Decré, et al.. (2021). Spontaneous and postsurgical/traumatic Klebsiella pneumoniae meningitis: two distinct clinico-microbiological entities. International Journal of Infectious Diseases. 114. 185–191. 5 indexed citations
8.
Noussair, Latifa, et al.. (2018). Evaluation of the culture-enhanced Xpert MTB/RIF assay for the diagnosis of smear-negative tuberculosis. Médecine et Maladies Infectieuses. 49(6). 467–470. 2 indexed citations
9.
Fernández, Javier, Frédéric Bert, & Marie-Hélène Nicolas-Chanoine. (2016). The challenges of multi-drug-resistance in hepatology. Journal of Hepatology. 65(5). 1043–1054. 124 indexed citations
10.
Aissa, Nejla, Noémie Mayer, Frédéric Bert, et al.. (2015). A new mechanism to render clinical isolates ofEscherichia colinon-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain. Journal of Antimicrobial Chemotherapy. 71(1). 76–79. 8 indexed citations
11.
Bert, Frédéric, Béatrice Larroque, Cathérine Paugam‐Burtz, et al.. (2012). Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeand Infection after Liver Transplant, France. Emerging infectious diseases. 18(6). 908–916. 79 indexed citations
12.
Sersté, Thomas, Frédéric Bert, Véronique Leflon‐Guibout, et al.. (2011). Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites. Liver International. 31(4). 494–498. 12 indexed citations
13.
Weiss, Emmanuel, Souhayl Dahmani, Frédéric Bert, et al.. (2010). Early-onset pneumonia after liver transplantation: Microbiological findings and therapeutic consequences. Liver Transplantation. 16(10). 1178–1185. 52 indexed citations
14.
Pagès, Jean‐Marie, Jean‐Philippe Lavigne, Véronique Leflon‐Guibout, et al.. (2009). Efflux Pump, the Masked Side of ß-Lactam Resistance in Klebsiella pneumoniae Clinical Isolates. PLoS ONE. 4(3). e4817–e4817. 93 indexed citations
15.
Bert, Frédéric. (2008). Facteurs de risque et traitement des infections à Staphylococcus aureus méticilline-résistant. La Presse Médicale. 31(38).
16.
Cortès, Alexandre, Alain Sauvanet, Frédéric Bert, et al.. (2005). Effect of Bile Contamination on Immediate Outcomes after Pancreaticoduodenectomy for Tumor. Journal of the American College of Surgeons. 202(1). 93–99. 131 indexed citations
17.
Tazi, Khalid A., Richard Moreau, Philippe Hervé, et al.. (2005). Norfloxacin Reduces Aortic NO Synthases and Proinflammatory Cytokine Up-Regulation in Cirrhotic Rats: Role of Akt Signaling. Gastroenterology. 129(1). 303–314. 61 indexed citations
18.
Bert, Frédéric, Ludovic Lassel, François Durand, et al.. (2005). Risk Factors for Staphylococcus Aureus Infection in Liver Transplant Recipients. Liver Transplantation. 11(9). 1093–1099. 51 indexed citations
19.
Bert, Frédéric, Catherine Branger, & N Lambert-Zechovsky. (2004). Comparative Activity of β-Lactam Agents (Carbapenem Excepted) against <i>Pseudomonas aeruginosa</i> Strains with CARB or OXA β-Lactamases. Chemotherapy. 50(1). 31–34. 2 indexed citations
20.
Bert, Frédéric, et al.. (1998). Clinical Significance of Bacteremia Involving the ``Streptococcus milleri'' Group: 51 Cases and Review. Clinical Infectious Diseases. 27(2). 385–387. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maristela Pinheiro Freire Breakdown of academic impact, for papers by Heidrun Kerschner Breakdown of academic impact, for papers by Jin‐Yong Jeong Breakdown of academic impact, for papers by Belén Viñado Breakdown of academic impact, for papers by Shellee A. Grim Breakdown of academic impact, for papers by Hae Suk Cheong Breakdown of academic impact, for papers by E.-C. Kim Breakdown of academic impact, for papers by Laurel C. Preheim Breakdown of academic impact, for papers by M. Kalin Breakdown of academic impact, for papers by Miguel Montejo
Rankless by CCL
2026